Protalix Biotherapeutics Inc（PLX）价格预测PLXProtalix Biotherapeutics Inc

Alphio's PLX stock price prediction model matches the current Protalix Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.52 (+0.30%). The 1-week path is $2.50 (-0.46%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Protalix Biotherapeutics Inc is a good buy right now due to its strong recent earnings report showing a net income of $18.3 million for Q1 2026, translating to an EPS of $0.22, which is a significant improvement from the previous year's loss. Additionally, the company has reaffirmed its revenue guidance for 2026, projecting total revenues between $78 million and $83 million, which further supports investor confidence. However, the current RSI of 43.51 indicates that the stock is approaching oversold territory, which could present a buying opportunity. The main risk is the forward P/E ratio of 51.81, suggesting that the stock may be overvalued if growth does not materialize as expected.

Protalix Biotherapeutics Inc (PLX) last closed at $2.51, losing -6.69%. These facts feed the 1-day and 1-week PLX price prediction above.